Heart Transplant Recipients
📧 Sign up to get email alerts when something new happens for Heart Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients [Phase 2, Phase 3]
Clinical trial update for an intravenous iron supplement in heart transplant recipients; study phases 2 and 3 have completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation [Phase 2]
Phase 2 trial investigating rituximab therapy to prevent cardiac allograft vasculopathy in heart transplant recipients; the study was termin…
-
FDA label_change · 2015-11-13FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis, resulting in changes to the product labeling. Th…